BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Loxapine Succinate

An antipsychotic agent used in SCHIZOPHRENIA.

30+ PubMed studies analyzed · Evidence Score: 35.2

Research Domains

Loxapine Succinate has been studied across 7 research domains including ❤️ Cardiovascular, 🧘 Stress & Anxiety, 😴 Sleep, 🧠 Cognitive, 🧠 Focus & Attention. The primary research focus is ❤️ Cardiovascular with 20% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Loxapine Succinate, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Promazine
16 shared targets
Diphenhydramine
10 shared targets
chlorprothixene
7 shared targets
Flutamide
16 shared targets
Stanozolol
11 shared targets
Nicardipine
14 shared targets
Phenelzine
12 shared targets
Propanil
8 shared targets
Toxaphene
12 shared targets
vinpocetine
14 shared targets
Loading evidence profile...

This evidence profile for Loxapine Succinate is generated deterministically from 30 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.